The investigators conducted a retrospective chart review to examine the development of chronic kidney disease in patients with biopsy-proven lupus nephritis who had been followed up for at least 10 years.
To evaluate laboratory parameters during the early course of lupus nephritis and their association with long-term stability of kidney function, the researchers enrolled 433 patients between 2008 and 2017 and evaluated their laboratory results at baseline, 3, 6, and 12 months.
To build on their previous study, the researchers aimed to determine whether CD11b activation suppresses toll-like receptor-dependent proinflammatory signaling by controlling IL-1β, influences IL-1β through another mechanism, or does both.
An analysis of US claims data has identified the health care costs and utilization for patients with a new diagnosis of lupus nephritis.
To investigate the relevance of these lesions to the pathophysiology of lupus nephritis, researchers examined 205 kidney biopsy samples of patients with lupus nephritis and evaluated the clinical characteristics of the patients in whom these lesions were found.
To determine whether activation of the complement pathway contributes to thrombotic microangiopathy, researchers compared various blood tests and whole-genome sequencing results between patients with thrombotic microangiopathy with and without systemic lupus erythematosus.
New research offers insight on survival outcomes in patients with end-stage renal disease who undergo hemodialysis at home vs in-center. The findings were presented at ASN Kidney Week 2018.
A new study presented at ASN Kidney Week 2018 suggests that dietary approaches may aid in the prevention of end-stage renal disease.
Emerging data suggest that acute kidney injury may have long-term cerebrovascular consequences, including heightened dementia risk. Consultant360 spoke with Dr Jessica Kendrick from the University of Colorado Denver about her research in this area.
Consultant360 spoke with Min Jun, PhD, MScMed, MSc, BSc, whose study found that 2 key indicators of renal function may help assess the long-term risk of major clinical outcomes in type 2 diabetes.